Newstral
Article
Bbarrons.com on 2020-06-02 15:22
Buy Lilly, AbbVie and Merck, J.P. Morgan Says
Related news
- BAbbVie Stock Has 15% Upside, J.P. Morgan Analyst Saysbarrons.com
- BEli Lilly and 2 More Drug Stocks That Could Ride Out the Coronavirus Crisis, According to J.P. Morganbarrons.com
- GGlobal Thyroid Hormone Disorder Drug Market 2022-28 Growth by Leading Firms: Novo Nordisk,Sanofi,Merck,Eli Lilly,AstraZeneca,AbbViegalleonnews.com
- LEndocrinology Drugs Market Size, Key Opportunities, Strategic Assessment, Strong Revenue | Oprating Vendors: AbbVie, Merck, AstraZeneca, Eli Lilly, Sanofi, Novo Nordisk…liverpoolstudentmedia.com
- BBausch Spinoff Plan Could Double Your Money, J.P. Morgan Saysbarrons.com
- BBuy the Dip in Amazon Shares, J.P. Morgan Says3 min readbarrons.com
- BBuy Netflix Stock Because ‘The Witcher’ Is a Hit, J.P. Morgan Saysbarrons.com
- BQualcomm Stock Is Way Too Cheap. It’s Time to Buy, J.P. Morgan Says.1 min readbarrons.com
- BIt’s Hard to See a Way Forward for Mallinckrodt, J.P. Morgan Saysbarrons.com
- BSanofi Stock Is Undervalued, J.P. Morgan Saysbarrons.com
- Sell Pfizer To Buy Merck?Forbes
- MValeant’s stock plunges, but J.P. Morgan stays bullishmarketwatch.com
- Should You Buy AbbVie Stock After The Recent 7% Fall?Forbes
- BTesla Looks Just a Little Better to J.P. Morganbarrons.com
- BInsurance Stocks Are Cheap. Lincoln Could Double, J.P. Morgan Says.barrons.com
- BGE Stock Is an ‘Expensive Value Trap,’ J.P. Morgan Saysbarrons.com
- BNetflix Stock Is Still Underpriced, J.P. Morgan Saysbarrons.com
- BNIO’s Stock Price Can Double, J.P. Morgan Saysbarrons.com